# Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients

> **NCT02950103** · PHASE2 · TERMINATED · sponsor: **Secretaria de Estado da Saúde** · enrollment: 73 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Phosphoethanolamine

## Key facts

- **NCT ID:** NCT02950103
- **Lead sponsor:** Secretaria de Estado da Saúde
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-08
- **Primary completion:** 2017-03
- **Final completion:** 2019-09
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2019-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950103, "Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02950103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*